Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Transplantation

  Free Subscription


Articles published in Transpl Int

Retrieve available abstracts of 63 articles:
HTML format
Text format



Single Articles


    May 2017
  1. BADAWY A, Hamaguchi Y, Seo S, Kaido T, et al
    Evaluation of Safety of Concomitant Splenectomy in Living Donor Liver Transplantation.
    Transpl Int. 2017 May 17. doi: 10.1111/tri.12985.
    PubMed     Text format     Abstract available


  2. METSELAAR HJ, van den Berg A, Coenraad MJ
    Why we need fairer allocation rules for patients with hepatocellular carcinoma awaiting a liver transplant.
    Transpl Int. 2017 May 11. doi: 10.1111/tri.12980.
    PubMed     Text format     Abstract available


    April 2017
  3. ALVER SK, Lorenz DJ, Washburn K, Marvin MR, et al
    Comparison of two equivalent MELD scores for hepatocellular carcinoma patients using data from the United Network for Organ Sharing liver transplant waiting list registry.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12967.
    PubMed     Text format     Abstract available


  4. ALFERINK LJ, Oey RC, Hansen BE, Polak WG, et al
    The impact of infections on delisting patients from the liver transplantation waiting list.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12965.
    PubMed     Text format     Abstract available


  5. YASSEN AM, Elsarraf WR, Elmorshedi MA, Abdel Wahab M, et al
    Short-term effects of extracorporeal graft rinse versus circulatory graft rinse in living donor liver transplantation. A Prospective Randomized Controlled Trial.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12968.
    PubMed     Text format     Abstract available


  6. PEZZATI D, Ghinolfi D, Lai Q, Cirillo G, et al
    Use of donors with genitourinary malignancies for liver transplantation: A calculated risk?
    Transpl Int. 2017 Apr 8. doi: 10.1111/tri.12962.
    PubMed     Text format     Abstract available


    March 2017
  7. SGARABOTTO D, Fasolato S, Vianello F, Vittadello F, et al
    Antibiotic prophylaxis for preventing post orthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid?
    Transpl Int. 2017 Mar 23. doi: 10.1111/tri.12955.
    PubMed     Text format     Abstract available


  8. HARRIES L, Schrem H, Stahmeyer JT, Krauth C, et al
    High Resource Utilization in Liver Transplantation - How Strongly differ Costs between the Care Sectors and What are the Main Cost Drivers?
    Transpl Int. 2017 Mar 11. doi: 10.1111/tri.12950.
    PubMed     Text format     Abstract available


  9. ROLLER J, Glanemann M
    Keep the pressure! Correlation of hemodynamic instability after reperfusion and severity of acute kidney injury following liver transplantation.
    Transpl Int. 2017 Mar 7. doi: 10.1111/tri.12948.
    PubMed     Text format     Abstract available


    February 2017
  10. SCHNITZBAUER AA, Bechstein WO
    Equitable distribution in rare indications for liver transplantation: the dilemma of the too small tablecloth continues!
    Transpl Int. 2017 Feb 22. doi: 10.1111/tri.12942.
    PubMed     Text format     Abstract available


  11. GROSSI PA
    Liver Transplantation from donors with positive blood cultures: increased risk of graft failure or opportunity to expand the donor pool?
    Transpl Int. 2017 Feb 20. doi: 10.1111/tri.12939.
    PubMed     Text format     Abstract available


    January 2017
  12. BURRA P, Zanetto A
    Filling the gap between clinical trials and real life in the treatment of severe HCV recurrence after liver transplantation.
    Transpl Int. 2017 Jan 19. doi: 10.1111/tri.12917.
    PubMed     Text format     Abstract available


  13. DE BOER JD, Koopman JJ, Metselaar HJ, Braat AE, et al
    Liver transplantation with geriatric liver allografts: the current situation in Eurotransplant.
    Transpl Int. 2017 Jan 6. doi: 10.1111/tri.12914.
    PubMed     Text format     Abstract available


    December 2016
  14. HERZER K, Welzel TM, Spengler U, Hinrichsen H, et al
    Real-World Experience With Daclatasvir Plus Sofosbuvir +/- Ribavirin for Post-Liver Transplant HCV Recurrence and Severe Liver Disease.
    Transpl Int. 2016 Dec 24. doi: 10.1111/tri.12910.
    PubMed     Text format     Abstract available


    November 2016
  15. DE MARTIN E, Antonini TM, Coilly A, Pittau G, et al
    HCV and HEV recurrence after liver transplantation: one antiviral therapy for two viruses.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12898.
    PubMed     Text format     Abstract available


  16. O'LEARY JG, Fontana RJ, Brown K, Burton JR Jr, et al
    Efficacy and Safety of Simeprevir and Sofosbuvir With and Without Ribavirin in Subjects With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant: The Randomized GALAXY Study.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12896.
    PubMed     Text format     Abstract available


  17. HUAMAN MA, Vilchez V, Mei X, Shah MB, et al
    Decreased Graft Survival in Liver Transplant Recipients of Donors with Positive Blood Cultures: A review of the UNOS dataset.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12900.
    PubMed     Text format     Abstract available


  18. KALISVAART M, de Haan JE, Hesselink DA, Polak WG, et al
    The Postreperfusion Syndrome Is Associated With Acute Kidney Injury Following Donation After Brain Death Liver Transplantation.
    Transpl Int. 2016 Nov 19. doi: 10.1111/tri.12891.
    PubMed     Text format     Abstract available


    October 2016
  19. VOUTILAINEN SH, Kosola SK, Tervahartiala TI, Sorsa TA, et al
    Liver and serum expression of matrix metalloproteinases in asymptomatic pediatric liver transplant recipients.
    Transpl Int. 2016 Oct 23. doi: 10.1111/tri.12879.
    PubMed     Text format     Abstract available


  20. SINGAL AK, Fang X, Kaif M, Hasanin M, et al
    Primary Biliary Cirrhosis Has High Wait List Mortality Among Patients Listed For Liver Transplantation.
    Transpl Int. 2016 Oct 18. doi: 10.1111/tri.12877.
    PubMed     Text format     Abstract available


  21. STINE JG, Argo CK, Pelletier SJ, Maluf DG, et al
    Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis.
    Transpl Int. 2016 Oct 6. doi: 10.1111/tri.12855.
    PubMed     Text format     Abstract available


    September 2016
  22. NEVIERE R, Trinh-Duc P, Hulo S, Edme JL, et al
    Predictive value of exhaled nitric oxide and aerobic capacity for sepsis complications after liver transplantion.
    Transpl Int. 2016 Sep 20. doi: 10.1111/tri.12861.
    PubMed     Text format     Abstract available


    August 2016
  23. ROBERTSON FP, Magill LJ, Wright GP, Fuller B, et al
    A systematic review and meta-analysis of donor ischaemic preconditioning in liver transplantation.
    Transpl Int. 2016 Aug 26. doi: 10.1111/tri.12849.
    PubMed     Text format     Abstract available


    July 2016
  24. PAMECHA V, Mahansaria SS, Kumar S, Bharathy KG, et al
    Association of thrombocytopenia with outcome following adult living donor liver transplantation.
    Transpl Int. 2016 Jul 18. doi: 10.1111/tri.12819.
    PubMed     Text format     Abstract available


  25. PITCHAIMUTHU M, Roll GR, Zia Z, Olliff S, et al
    Long-term follow-up after endovascular treatment of hepatic venous outflow obstruction following liver transplantation.
    Transpl Int. 2016 Jul 2. doi: 10.1111/tri.12817.
    PubMed     Text format     Abstract available


    May 2016
  26. TESTINO G
    Alcohol and liver transplantation: the six-month abstinence rule is not a dogma.
    Transpl Int. 2016 May 9. doi: 10.1111/tri.12790.
    PubMed     Text format     Abstract available


    April 2016
  27. LEE KW, Lee S, Dong Kyu O, Na BG, et al
    Outcome of Partial Reconstruction of Multiple Hepatic Arteries in Pediatric Living Donor Liver Transplantation Using Left Liver Grafts.
    Transpl Int. 2016 Apr 26. doi: 10.1111/tri.12787.
    PubMed     Text format     Abstract available


  28. BRANDL A, Stolzlechner P, Eschertzhuber S, Aigner F, et al
    Inferior graft survival of hepatitis B core positive grafts is not influenced by post-transplant hepatitis B infection in liver recipients--5-year single-center experience.
    Transpl Int. 2016;29:471-82.
    PubMed     Text format     Abstract available


    March 2016
  29. TIAN Y, Lesurtel M, Ungethuem U, Song Z, et al
    A novel technique in mouse liver transplantation (with video).
    Transpl Int. 2016 Mar 31. doi: 10.1111/tri.12780.
    PubMed     Text format     Abstract available


  30. IJTSMA AJ, van der Hilst CS, Nijkamp DM, Bottema JT, et al
    Does The MELD System Provide Equal Access to Liver Transplantation for Patients with Different ABO Blood Groups?
    Transpl Int. 2016 Mar 14. doi: 10.1111/tri.12774.
    PubMed     Text format     Abstract available


    February 2016
  31. KOLLMANN D, Rasoul-Rockenschaub S, Steiner I, Freundorfer E, et al
    Good outcome after liver transplantation for ALD without a 6-months abstinence rule prior to transplantation including post-transplant CDT-monitoring for alcohol relapse assessment - a retrospective study.
    Transpl Int. 2016 Feb 10. doi: 10.1111/tri.12756.
    PubMed     Text format     Abstract available


  32. ELDEEN FZ, Mourad MM, Bhandari M, Roll G, et al
    Accepting multiple simultaneous liver offers does not negatively impact transplant outcomes.
    Transpl Int. 2016;29:227-33.
    PubMed     Text format     Abstract available


    January 2016
  33. KIVELA JM, Kosola S, Perasaari J, Makisalo H, et al
    Donor-specific antibodies after pediatric liver transplantation: a cross-sectional study of 50 patients.
    Transpl Int. 2016 Jan 25. doi: 10.1111/tri.12747.
    PubMed     Text format     Abstract available


  34. ZHONG Z, Ye S, Xiong Y, Wu L, et al
    Decreased expression of mitochondrial aldehyde dehydrogenase-2 induces liver injury via activation of the mitogen-activated protein kinase pathway.
    Transpl Int. 2016;29:98-107.
    PubMed     Text format     Abstract available


  35. PANDANABOYANA S, Longbotham D, Hostert L, Attia M, et al
    Transplantation of liver and kidney from donors with malignancy at the time of donation: an experience from a single centre.
    Transpl Int. 2016;29:73-80.
    PubMed     Text format     Abstract available


    December 2015
  36. RODRIGUEZ-PERALVAREZ M, Rico-Juri JM, Tsochatzis E, Burra P, et al
    Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.
    Transpl Int. 2015 Dec 29. doi: 10.1111/tri.12737.
    PubMed     Text format     Abstract available


  37. RUSSO FP, Zanetto A, Burra P
    Timing for treatment of HCV recurrence after liver transplantation: the earlier the better.
    Transpl Int. 2015 Dec 29. doi: 10.1111/tri.12739.
    PubMed     Text format     Abstract available


  38. LIESE J, Peveling-Oberhag J, Doering C, Schnitzbauer AA, et al
    A possible role of miRNAs as predictive markers for the recurrence of hepatocellular carcinoma after liver transplantation.
    Transpl Int. 2015 Dec 23. doi: 10.1111/tri.12733.
    PubMed     Text format     Abstract available


  39. GAMBATO M, Crespo G, Torres F, LLovet L, et al
    Simple prediction of long-term clinical outcomes in patients with mild hepatitis c recurrence after liver transplantation.
    Transpl Int. 2015 Dec 11. doi: 10.1111/tri.12730.
    PubMed     Text format     Abstract available


    November 2015
  40. ROBERTSON FP, Bessell PR, Diaz-Nieto R, Thomas N, et al
    High serum Aspartate Transaminase (AST) levels on day 3 post liver transplantation correlates with graft and patient survival and would be a valid surrogate for outcome in liver transplantation clinical trials.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12723.
    PubMed     Text format     Abstract available


  41. LIBRIZZI S, Guadalix S, Martinez-Diaz Guerra G, Allo G, et al
    Trabecular bone sc0re in patients with liver transplants after one year of risedronate treatment.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12725.
    PubMed     Text format     Abstract available


    October 2015
  42. DARWISH MURAD S, Metselaar HJ
    The invasion of fatty liver disease in liver transplantation.
    Transpl Int. 2015 Oct 24. doi: 10.1111/tri.12707.
    PubMed     Text format     Abstract available


    September 2015
  43. ALKHOURI N, Hanouneh IA, Zein NN, Lopez R, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis (NASH) in Young Patients.
    Transpl Int. 2015 Sep 24. doi: 10.1111/tri.12694.
    PubMed     Text format     Abstract available


    August 2015
  44. ARRIZZA C, De Gottardi A, Foglia E, Baumgartner M, et al
    Reversal of cardiomyopathy in propionic acidemia after liver transplantation: a 10-year follow-up.
    Transpl Int. 2015 Aug 27. doi: 10.1111/tri.12677.
    PubMed     Text format     Abstract available


  45. BELLO AD, Congy-Jolivet N, Danjoux M, Muscari F, et al
    De novo Donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients.
    Transpl Int. 2015 Aug 25. doi: 10.1111/tri.12654.
    PubMed     Text format     Abstract available


  46. O'LEARY JG
    Donor-specific alloantibodies in liver transplantation: How should we define and improve long-term success?
    Transpl Int. 2015 Aug 18. doi: 10.1111/tri.12661.
    PubMed     Text format     Abstract available


  47. UEDA Y, Uemoto S
    Decreased tacrolimus concentration following a temporal increase during interferon-free therapy with asunaprevir and daclatasvir in patients with recurrent hepatitis C after liver transplantation.
    Transpl Int. 2015 Aug 13. doi: 10.1111/tri.12653.
    PubMed     Text format     Abstract available


    July 2015
  48. BURRA P, De Martin E, Zanetto A, Senzolo M, et al
    "HCV and liver transplantation: where do we stand?"
    Transpl Int. 2015 Jul 21. doi: 10.1111/tri.12642.
    PubMed     Text format     Abstract available


  49. BHAT M, Hathcock M, Kremers WK, Darwish Murad S, et al
    Portal Vein Encasement Predicts Neoadjuvant Therapy Response in Liver Transplantation for Perihilar Cholangiocarcinoma protocol.
    Transpl Int. 2015 Jul 16. doi: 10.1111/tri.12640.
    PubMed     Text format     Abstract available


  50. SPETZLER VN, Goldaracena N, Kaths JM, Marquez M, et al
    High Pre-operative Bilirubin Values Protect Against Reperfusion Injury after Live Donor Liver Transplantation.
    Transpl Int. 2015 Jul 6. doi: 10.1111/tri.12634.
    PubMed     Text format     Abstract available


  51. LEVESQUE E, Paugam-Burtz C, Saliba F, Khoy-Ear L, et al
    Fungal complications after Candida preservation fluid contamination in liver-transplant recipients.
    Transpl Int. 2015 Jul 6. doi: 10.1111/tri.12633.
    PubMed     Text format     Abstract available


  52. HOUBEN P, Manzini G, Kremer M, Arend J, et al
    Graft rinse prior to reperfusion in liver transplantation: Literature review and online survey within the Eurotransplant community.
    Transpl Int. 2015 Jul 6. doi: 10.1111/tri.12631.
    PubMed     Text format     Abstract available


  53. THOMAS MN, Nadalin S, Schemmer P, Pascher A, et al
    A German survey of the abdominal transplantation surgical work force.
    Transpl Int. 2015;28:849-56.
    PubMed     Text format     Abstract available


  54. HALDAR D, Chen F, Byron J, Elsharkawy AM, et al
    Is it time to revisit contraindications to organ donation from donors with a JAK-2 mutation? Safe use of a liver allograft from a donor with essential thrombocythaemia.
    Transpl Int. 2015;28:881-3.
    PubMed     Text format     Abstract available


    June 2015
  55. BONACCI M, Londono MC, Esforzado N, Forns X, et al
    Antiviral Treatment with Sofosbuvir and Simeprevir in a Kidney-Transplant Recipient with HCV-Decompensated Cirrhosis: Viral Eradication and Removal from the Liver Transplant Waiting List.
    Transpl Int. 2015 Jun 13. doi: 10.1111/tri.12622.
    PubMed     Text format     Abstract available


  56. UCHIDA H, Fukuda A, Sasaki K, Miyasaka M, et al
    Donor Double Common Bile Duct in Living Donor Liver Transplantation.
    Transpl Int. 2015 Jun 5. doi: 10.1111/tri.12619.
    PubMed     Text format     Abstract available


    May 2015
  57. BHATTI AB, Dar FS, Zia H
    Where Angels Fear to Tread: Donor Bile Duct Division in Living Donor Liver Transplant.
    Transpl Int. 2015 May 27. doi: 10.1111/tri.12613.
    PubMed     Text format     Abstract available


  58. KURAMITSU K, Fukumoto T, Yano Y, Hirano H, et al
    A case of intravascular lymphoma diagnosed in an explanted liver after liver transplantation.
    Transpl Int. 2015 May 23. doi: 10.1111/tri.12611.
    PubMed     Text format     Abstract available


    March 2015
  59. WESTERKAMP AC, de Boer MT, van den Berg AP, Gouw AS, et al
    Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
    Transpl Int. 2015;28:319-29.
    PubMed     Text format     Abstract available


    February 2015
  60. WATT KD
    Is 40 the new 30?
    Transpl Int. 2015;28:146-7.
    PubMed     Text format    


  61. TRIPON S, Francoz C, Albuquerque A, Paradis V, et al
    Interactions between virus-related factors and post-transplant ascites in patients with hepatitis C and no cirrhosis: role of cryoglobulinemia.
    Transpl Int. 2015;28:162-9.
    PubMed     Text format     Abstract available


    August 2014
  62. INDOLFI G, Berczes R, Pelliccioli I, Bosisio M, et al
    Neonatal haemochromatosis with reversible pituitary involvement.
    Transpl Int. 2014;27:e76-9.
    PubMed     Text format     Abstract available


    May 2014
  63. ALMEIDA-PAULO GN, Lubomirov R, Alonso-Sanchez NL, Espinosa-Roman L, et al
    Limited Sampling Strategies For Tacrolimus Exposure (Auc ) Prediction After Prograf And Advagraf Administration In Children And Adolescents With Liver Or Kidney Transplants.
    Transpl Int. 2014 May 27. doi: 10.1111/tri.12362.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: